Federal Judge To Get Status Report Today from Ryan White Clinics and Government

HIV/AIDS clinics' and community health centers' lawsuits to force HHS to act against drug manufacturers denying 340B pricing are both being heard in federal district court in Washington, D.C.

Ryan White Clinics for 340B Access (RWC-340B) and the federal government have a deadline today to report to a federal judge about whether to continue the stay in the group’s suit to force the government to act against drug manufacturers

Read More »

Drug Pricing Is Heating Up in Congress Again

Sen. Bernie Sanders (I-Vt.) chaired today's Senate HELP subcommittee hearing on why the United States pays the highest prices in the world for prescription drugs.

A few years ago, there was hope that congressional Democrats and Republicans and the Trump administration would unite and enact legislation addressing the high price of prescription drugs.

It never happened. House Democrats passed a far-ranging drug pricing bill in

Read More »

Survey: Pharma’s 340B Contract Pharmacy Actions are Putting the Squeeze on Hospitals

Nearly all (97 percent) of all 340B hospitals in a recent survey said they are impacted by drug manufacturers' curbs on contract pharmacy use. | Shutterstock

340B hospitals are under significant pressure due to drug manufacturers ending 340B discounts on drugs dispensed by contract pharmacies, hospital advocacy group 340B Health says in its latest annual member survey.

Nearly 500 hospitals that are members of 340B

Read More »

Health Centers Get Reprieve as 340B Insulin Pricing Rule Delayed Again

HHS has for the second time delayed the effective date of a Trump administration rule to require health centers to provide insulin and injectable epinephrine to low-income patients at the price the centers pay for those drugs under the 340B program. The new date is July 20. | Shutterstock

The U.S. Health and Human Services Department (HHS) announced late this morning that it will delay, from this coming Monday, March 22 until July 20, the effective date of a Trump administration rule to require health centers to provide insulin

Read More »

Becerra Expected To Usher in Sea Change to 340B Governance

With Xavier Becerra in place as HHS secretary, 340B providers are hopeful he will act fast and decisively against drug manufacturers that have either stopped providing 340B discounts or placed restrictions on 340B pricing in the contract pharmacy setting. | Shutterstock

Updated, Friday, March 19, 9:30 a.m. EDT—After what initially appeared to be a rocky path to confirmation and a deadlocked vote in the U.S. Senate Finance Committee, California Attorney General Xavier Becerra (D) was confirmed today, by a 50-49 vote,

Read More »

Six Senators Reintroduce Bipartisan Bill to Protect 340B Hospitals From COVID Fallout

Sen. John Thune (R-S.D.) his and his six Senate colleagues' bipartisan bill "would ensure that no hospital that is currently participating in the 340B program can lose eligibility due to a reduction in hospitalizations during the pandemic." | C-SPAN

A bipartisan group of six U.S. senators on Tuesday reintroduced legislation from the last session of Congress to protect hospitals from losing eligibility for 340B drug discounts during the COVID-19 pandemic.

Five of the six types of hospitals that can

Read More »
Industry Insights Logo

The Patient Journey: Are You Missing Something?

SPONSORED CONTENT

Do you provide clinical care for patients living with or at risk of HIV? If so, you know how important it is to consider their needs beyond the clinic visit.

The patient journey is not linear. Social stigma, family issues, mental health challenges, financial hardship,

Read More »

Sanders Holding Senate Hearing on Drug Prices Next Week

Sen. Bernie Sanders (I-Vt.) a Senate Democratic letter to PhRMA last September decrying drug companies' denials of and conditions on 340B contract pharmacy drugs. | C-SPAN

U.S. Sen. Bernie Sanders (I-Vt.) has scheduled a hearing next Tuesday of the U.S. Senate health subcommittee he chairs on why the United States pays the highest prices in the world for prescription drugs.

The Senate Health, Education, Labor, and

Read More »

Amazon Is Opening its Employees-only Primary and Urgent Care Service to Companies Nationwide

Amazon Care, the online retailer's expanded telehealth and home-visit health care service, includes “prescription delivery right to a patient’s door.” | Amazon

Online retailer Amazon announced yesterday that it began offering companies in Washington state access to its Amazon Care telehealth and home-visit primary and urgent health care services, which include “prescription delivery right to a patient’s door.”

Until now, Amazon

Read More »

Injunction in Lilly Case Could Cause HHS to Re-Issue 340B Dispute Resolution Rule

Drug manufacturer Eli Lilly said it is pleased with a court's injunction yesterday stopping 340B dispute resolution proceedings against it over its denials of 340B pricing on contract pharmacy drugs. | Shutterstock

A federal judge’s decision to temporarily shield drug manufacturer Eli Lilly from the 340B program’s administrative dispute resolution (ADR) process could cause the government to issue 340B ADR regulations all over again, health care attorneys say.

U.S. District Judge Sarah

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live